« Back
Home /
IPG7236

IPG7236

Item no.	DCC-DC65220-100mg
Manufacturer	DCChemicals
Amount	100 mg
Category	Reagents & Chemicals Other Chemicals
Type	Chemicals
Specific against	other
Smiles	O=C(NC1=CC=C(S(=O)(N[C@@H](C2CCN(C)CC2)C)=O)C=C1C)C3=CC=CC=C3C
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Available
Molecule Weight	429, 58
Field of Application	IPG7236 is a CCR8 antagonist that through the modulation of regulatory T-cells and cytotoxic T (CD8+ T) cells, displays anticancer effects. IPG7236 is currently undergoing Phase 1 clinical trials in the treatment of advanced solid tumors.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 10/11/2024

Express Delivery: Save 1 days

Compare

Add to wishlist

Recommend by mail